Ironwood Pharmaceuticals IRWD Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $361.51M+22.1% | $296.15M-12.6% | $338.99M+9.9% | $308.52M-2.9% | $317.68M-9.6% | ||
| $89.64M-5.8% | $95.14M-3.6% | $98.66M-6.9% | $106.02M-6.2% | $113.04M+1.5% | ||
| $70.03M-14.9% | $82.26M-14.8% | $96.55M-12.8% | $110.76M-15.4% | $130.93M-9.2% | ||
| $161.33M-18.4% | $197.65M-8.4% | $215.8M-8.2% | $235.18M-11.1% | $264.68M+2.5% | ||
| $200.18M+103% | $98.5M-20.0% | $123.19M+68.0% | $73.34M+38.4% | $53M-43.1% | ||
| 55.4%+22.1pp | 33.3%-3.1pp | 36.3%+12.6pp | 23.8%+7.1pp | 16.7%-9.8pp | ||
| $33.82M+3.3% | $32.75M-3.0% | $33.77M-2.8% | $34.76M+2.6% | $33.87M+2.5% | ||
| $4.91M+20.3% | $4.08M+20.1% | $3.4M-6.1% | $3.62M-13.2% | $4.17M-6.7% | ||
| -$28.71M-0.8% | -$28.48M+3.9% | -$29.62M+2.6% | -$30.43M-4.8% | -$29.03M-3.9% | ||
| $171.47M+145% | $70.03M-25.2% | $93.57M+118% | $42.91M+79.0% | $23.97M-63.2% | ||
| $69.29M+50.6% | $46.01M-29.2% | $65.02M+28.0% | $50.8M-9.8% | $56.31M-12.4% | ||
| $102.18M+325% | $24.02M-15.9% | $28.55M+462% | -$7.89M+75.6% | -$32.34M-3,775% | ||
| 28.3%+20.2pp | 8.1%-0.3pp | 8.4%+11.0pp | -2.6%+7.6pp | -10.2%-10.4pp | ||
| $0.60+362% | $0.13-13.3% | $0.15+350% | -$0.06+71.4% | -$0.21-2,000% | ||
| $0.64+300% | $0.16-11.1% | $0.18+460% | -$0.05+76.2% | -$0.21-2,000% | ||
| 684.3M+0.8% | 678.6M+0.4% | 675.7M+2.7% | 658.1M+2.8% | 640.3M+0.5% | ||
| 649.2M+0.4% | 646.8M+0.4% | 644M+0.4% | 641.5M+0.4% | 638.8M+0.5% | ||
| $61.07M+43.5% | $42.55M-49.1% | $83.65M+31.6% | $63.56M+1.4% | $62.71M-7.9% | ||
| $1.85M-1.9% | $1.88M-1.3% | $1.91M-1.7% | $1.94M-2.0% | $1.98M-1.7% | ||
| —— | —— | —— | —— | —— | ||
| —— | $3.54M-25.6% | $4.76M-20.4% | $5.98M-16.9% | $7.19M-14.5% | ||
| -$8.03M-223% | $6.52M+750% | $767K+108% | -$9.93M-619% | $1.91M+109% | ||
| $66.07M+288% | -$35.15M— | —— | —— | —— | ||
| -$2.42M-2.1% | -$2.37M-2.2% | -$2.32M-2.2% | -$2.27M-2.1% | -$2.23M-2.3% | ||
| $3.7M-9.9% | $4.11M+123% | -$17.57M-31.6% | -$13.35M-18.8% | -$11.24M-9.6% | ||
| -$427K+4.5% | -$447K— | —— | —— | —— | ||
| -$6.77M-1,745% | -$367K+76.3% | -$1.55M— | —— | —— | ||
| —— | $30.33M-1.8% | $30.89M-1.8% | $31.45M-1.7% | $32.01M-1.7% | ||
| $4.91M+20.3% | $4.08M+20.1% | $3.4M-6.1% | $3.62M-13.2% | $4.17M-6.7% | ||
| —— | $216K+101% | -$14.79M+64.7% | -$41.95M+54.1% | -$91.41M+14.5% | ||
| —— | -$35K0.0% | -$35K+28.6% | -$49K+53.3% | -$105K+26.1% | ||
| —— | —— | —— | —— | $78.52M-24.2% | ||
| $1.72M+2.1% | $1.69M+2.0% | $1.66M+2.0% | $1.62M+2.1% | $1.59M+2.0% | ||
| $198K+2.6% | $193K-30.1% | $276K-30.3% | $396K-23.4% | $517K-19.2% | ||
| —— | $35K0.0% | $35K-28.6% | $49K-53.3% | $105K-26.1% | ||
| —— | $216K-27.3% | $297K0.0% | $297K-69.0% | $958K-91.3% | ||
| $1.91M-90.7% | $20.51M-0.4% | $20.58M+11.9% | $18.4M-11.2% | $20.72M+699% | ||
| $361.51M+22.1% | $296.15M-12.6% | $338.99M+9.9% | $308.52M-2.9% | $317.68M-9.6% | ||
| $15.61M-9.5% | $17.25M-4.1% | $17.99M-20.8% | $22.71M-15.1% | $26.76M-10.4% | ||
| $200.18M+103% | $98.5M-20.0% | $123.19M+68.0% | $73.34M+38.4% | $53M-43.1% | ||
| $202.03M+101% | $100.38M-19.6% | $124.91M+66.8% | $74.89M+37.7% | $54.38M-42.4% | ||
| $202.03M+101% | $100.38M-19.6% | $124.91M+66.8% | $74.89M+37.7% | $54.38M-42.4% | ||
| 55.9%+22.0pp | 33.9%-3.0pp | 36.8%+12.6pp | 24.3%+7.2pp | 17.1%-9.7pp | ||
| $200.18M+103% | $98.5M-20.0% | $123.19M+68.0% | $73.34M+38.4% | $53M-43.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Ironwood Pharmaceuticals's revenue?
- Ironwood Pharmaceuticals (IRWD) generated $361.5M in revenue over the trailing twelve months, up 13.8% year over year.
- Is Ironwood Pharmaceuticals profitable?
- Ironwood Pharmaceuticals reported $102.2M in net income over the trailing twelve months, a 28.3% net margin.
- What are Ironwood Pharmaceuticals's profit margins?
- Gross margin is 99.2% and operating margin is 55.4%, with a 28.3% net margin.
- What is Ironwood Pharmaceuticals's earnings per share?
- Ironwood Pharmaceuticals's diluted EPS over the trailing twelve months is $0.60.
- Where does Ironwood Pharmaceuticals's income statement data come from?
- Every line is extracted from Ironwood Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
